1990 to 2021 Saw Increase in Global Burden of Diabetic Nephropathy
Burden is projected to continue increasing through 2050, and is related to sociodemographic index
Considerable Proportion of Medical Device Adverse Events Reported Late
9.1 percent were reported after 180 days; small number of manufacturers submitted most of the late reports
Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk
Medium and high T2DM genetic risk not linked to increased risk for ASCVD when TV viewing is no more than one hour/day
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
No benefits seen in terms of weight loss, diabetes remission, surgery safety
Americans Borrowed $74 Billion in 2024 to Cover Medical Costs
Survey reveals many Americans worry they will incur medical debt if they experience a major medical event
Americans Borrowed $74 Million in 2024 to Cover Medical Costs
Survey reveals many Americans worry they will incur medical debt if they experience a major medical event
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin
Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults
However, glycemic control worsened, with the trend most pronounced among younger adults aged 20 to 44 years
Continuous Glucose Monitors Overestimate Glycemic Responses
Variation in CGM bias by postprandial test, with glycemic index for commercial fruit smoothie higher with CGM versus capillary sampling
Global Increases in Obesity Set to Continue in Children, Teens to 2050
And, the total number of adults living with overweight and obesity projected to reach 3.80 billion by 2050
